Compassionate Use of Remdesivir for Patients with Severe Covid-19 | Zendy

Jonathan Grein | Zendy; Norio Ohmagari | Zendy; Daniel D. Shin | Zendy; George Diaz | Zendy; Erika Asperges | Zendy; Antonella Castagna | Zendy; Torsten Feldt | Zendy; Gary Green | Zendy; Margaret L. Green | Zendy; François-Xavier Lescure | Zendy; Emanuele Nicastri | Zendy; Rentaro Oda | Zendy; Kikuo Yo | Zendy; Eugenia Quirós-Roldán | Zendy; Alex Studemeister | Zendy; John Redinski | Zendy; Seema Ahmed | Zendy; Jorge R Bernett | Zendy; Daniel Chelliah | Zendy; Danny Chen | Zendy; Shingo Chihara | Zendy; Stuart H. Cohen | Zendy; Jennifer Cunningham | Zendy; Antonella d’Arminio Monforte | Zendy; Saad Ismail | Zendy; Hideaki Kato | Zendy; Giuseppe Lapadula | Zendy; Erwan L’Her | Zendy; Toshitaka Maeno | Zendy; Sumit Majumder | Zendy; Marco Massari | Zendy; Marta Mora-Rillo | Zendy; Yoshikazu Mutoh | Zendy; Duc Nguyen | Zendy; E. Verweij | Zendy; Alexander Zoufaly | Zendy; Anu Osinusi | Zendy; Adam DeZure | Zendy; Yang Zhao | Zendy; Lijie Zhong | Zendy; Anand P. Chokkalingam | Zendy; Emon Elboudwarej | Zendy; Laura Telep | Zendy; Leighann Timbs | Zendy; Ila. Henne | Zendy; Scott Sellers | Zendy; Huyen Cao | Zendy; Susanna K. Tan | Zendy; Lucinda Winterbourne | Zendy; Polly Desai | Zendy; Robertino M. Mera | Zendy; Anuj Gaggar | Zendy; Robert P. Myers | Zendy; Diana M. Brainard | Zendy; Richard W. Childs | Zendy; Timothy Flanigan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Author(s) -

Jonathan Grein,

Norio Ohmagari,

Daniel D. Shin,

George Diaz,

Erika Asperges,

Antonella Castagna,

Torsten Feldt,

Gary Green,

Margaret L. Green,

François-Xavier Lescure,

Emanuele Nicastri,

Rentaro Oda,

Kikuo Yo,

Eugenia Quirós-Roldán,

Alex Studemeister,

John Redinski,

Seema Ahmed,

Jorge R Bernett,

Daniel Chelliah,

Danny Chen,

Shingo Chihara,

Stuart H. Cohen,

Jennifer Cunningham,

Antonella d’Arminio Monforte,

Saad Ismail,

Hideaki Kato,

Giuseppe Lapadula,

Erwan L’Her,

Toshitaka Maeno,

Sumit Majumder,

Marco Massari,

Marta Mora-Rillo,

Yoshikazu Mutoh,

Duc Nguyen,

E. Verweij,

Alexander Zoufaly,

Anu Osinusi,

Adam DeZure,

Yang Zhao,

Lijie Zhong,

Anand P. Chokkalingam,

Emon Elboudwarej,

Laura Telep,

Leighann Timbs,

Ila. Henne,

Scott Sellers,

Huyen Cao,

Susanna K. Tan,

Lucinda Winterbourne,

Polly Desai,

Robertino M. Mera,

Anuj Gaggar,

Robert P. Myers,

Diana M. Brainard,

Richard W. Childs,

Timothy Flanigan

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2007016

Subject(s) - covid-19 , betacoronavirus , compassionate use , virology , medicine , coronavirus infections , coronavirus , outbreak , infectious disease (medical specialty) , disease , clinical trial

In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy. (Funded by Gilead Sciences.).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research